Dalmia Bharat Ltd (DALBHARAT) Q1 FY27 Results Analysis: PAT Plunges 51%, Margin Compresses 359 bps

CompoundingAI Research Updated July 24, 2026 2 min read
Negative

Dalmia Bharat Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 3,890.00 Cr (+7.00% YoY) and PAT growth of -51.40% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 24, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 3,890.00 Cr (+7.00% YoY)
PAT (Q1)Rs. 192.00 Cr (-51.40% YoY)
EBITDA margin20.69% (-359 bps YoY)
EPS (Q1)Rs. 10.02 (-52.20% YoY)
Market capRs. 33,953.46 Cr
CMPRs. 1,810.80

Quarter Snapshot

Dalmia Bharat reported a weak Q1 FY27 with PAT down 51% YoY and EBITDA margin compressing 359 bps, driven by power & fuel cost inflation and a Rs.182 Cr exceptional charge from the JAL acquisition. While revenue grew 7% YoY on volume, cost headwinds from the West Asia conflict and INR depreciation eroded profitability. The JAL acquisition provides long-term strategic benefits but adds near-term debt and integration costs, making the outlook cautious.

Key Investment Insights

Key Positives

  • Revenue grew 7.0% YoY to Rs.3,890 Cr, driven by volume growth in line with industry production (+8.3% Apr–May 2026).
  • JAL acquisition completed on May 29, 2026, adding Chunar grinding unit from June 20 and strengthening Central region presence.
  • Capacity expansion on track for 75 MnTPA by FY28 and 61.5 MnTPA by Oct 2027.

Risk Factors

  • PAT declined 51.4% YoY to Rs.192 Cr due to cost inflation and a Rs.182 Cr exceptional charge.
  • EBITDA margin compressed 359 bps YoY to 20.69%, driven by power & fuel (+194 bps) and other expenses (+142 bps).
  • Finance costs rose 36.1% YoY to Rs.147 Cr due to debt-funded JAL acquisition and capex.
  • Exceptional charge of Rs.182 Cr (JAL acquisition costs Rs.177 Cr, labour codes Rs.5 Cr) depressed reported earnings.
  • Auditor emphasized Bawri Group dispute and Allied Financial case as material uncertainties.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now